Mechanisms linking metabolic-associated fatty liver disease (MAFLD) to cardiovascular disease

OO Badmus, TD Hinds Jr, DE Stec - Current hypertension reports, 2023 - Springer
Abstract Purpose of Review Metabolic-associated fatty liver disease (MAFLD) is a condition
of fat accumulation in the liver that occurs in the majority of patients in combination with …

Fetuin-A: a novel link between obesity and related complications

JF Trepanowski, J Mey, KA Varady - International journal of obesity, 2015 - nature.com
Fetuin-A (FetA) is a 64-kDa glycoprotein that is secreted from both the liver and adipose
tissue. Circulating FetA is elevated in obesity and related disorders including type 2 diabetes …

Pathophysiological implication of fetuin-A glycoprotein in the development of metabolic disorders: a concise review

L Bourebaba, K Marycz - Journal of Clinical Medicine, 2019 - mdpi.com
Alpha 2-Heremans-Schmid glycoprotein, also known as fetuin-A (Fet-A), is a multifunctional
plasma glycoprotein that has been identified in both animal and human beings. The protein …

Effect of a 12-week aerobic exercise training on serum fetuin-A and adipocytokine levels in type 2 diabetes

LY Zhang, T Liu, YQ Teng, XY Yao… - Experimental and …, 2018 - thieme-connect.com
Objective We aimed to evaluate the effect of 12-week aerobic exercise training on fetuin-A
levels in type 2 diabetes mellitus and examine the relationships between fetuin-A and …

[PDF][PDF] Fetuin-A (AHSG) and its usefulness in clinical practice. Review of the literature

AM Dabrowska, JS Tarach… - Biomed Pap Med …, 2015 - biomed.papers.upol.cz
Background. Fetuin-A, also called Alpha 2-Heremans Schmid Glycoprotein, is a
multifunctional plasma agent what has been proven in animal and human studies. It plays a …

Clinical implications of fetuin-A

P Jirak, L Stechemesser, E Moré, M Franzen… - Advances in clinical …, 2019 - Elsevier
Fetuin-A, also termed alpha2-Heremans-Schmid glycoprotein, is a 46 kDa hepatocyte
derived protein (hepatokine) and serves multifaceted functions.(i) It acts as systemic inhibitor …

[HTML][HTML] Hepatokines as a link between obesity and cardiovascular diseases

HJ Yoo, KM Choi - Diabetes & metabolism journal, 2015 - synapse.koreamed.org
Non-alcoholic fatty liver disease, which is considered a hepatic manifestation of metabolic
syndrome, independently increases the risks of developing cardiovascular disease (CVD) …

Fetuin-A and risk of diabetes-related vascular complications: a prospective study

A Birukov, E Polemiti, S Jäger, N Stefan… - Cardiovascular …, 2022 - Springer
Background Fetuin-A is a hepatokine which has the capacity to prevent vascular
calcification. Moreover, it is linked to the induction of metabolic dysfunction, insulin …

Biomarkers of vascular calcification and mortality in patients with ESRD

JJ Scialla, WHL Kao, C Crainiceanu… - Clinical Journal of the …, 2014 - journals.lww.com
Biomarkers of Vascular Calcification and Mortality in Patien... : Clinical Journal of the
American Society of Nephrology Biomarkers of Vascular Calcification and Mortality in …

[HTML][HTML] The role of fetuin-A in mineral trafficking and deposition

MMX Cai, ER Smith, SG Holt - BoneKEy reports, 2015 - ncbi.nlm.nih.gov
Calcium and phosphate are the principle ions involved in the deposition of mineral in the
human body. Inhibitors of mineralisation are essential for the prevention of ectopic mineral …